Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. [electronic resource]
Producer: 20140106Description: 400-15 p. digitalISSN:- 1862-1783
- Arrhythmias, Cardiac -- mortality
- Cardiotonic Agents -- therapeutic use
- Comorbidity
- Critical Illness -- mortality
- Dobutamine -- therapeutic use
- Evidence-Based Medicine
- Heart Failure -- drug therapy
- Humans
- Hydrazones -- therapeutic use
- Hypotension -- mortality
- Pyridazines -- therapeutic use
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Risk Factors
- Simendan
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.